References
- Leibbrandt A and Penninger JM (2008) RANK/RANKL: regulators of immune responses and bone physiology. Ann N Y Acad Sci 1143, 123-150 https://doi.org/10.1196/annals.1443.016
- Kim JH and Kim N (2016) Signaling Pathways in Osteoclast Differentiation. Chonnam Med J 52, 12-17 https://doi.org/10.4068/cmj.2016.52.1.12
- Takayanagi H, Kim S, Koga T et al (2002) Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev Cell 3, 889-901 https://doi.org/10.1016/S1534-5807(02)00369-6
- Katagiri T and Takahashi N (2002) Regulatory mechanisms of osteoblast and osteoclast differentiation. Oral Dis 8, 147-159 https://doi.org/10.1034/j.1601-0825.2002.01829.x
- Matsubara T, Kida K, Yamaguchi A et al (2008) BMP2 regulates Osterix through Msx2 and Runx2 during osteoblast differentiation. J Biol Chem 283, 29119-29125 https://doi.org/10.1074/jbc.M801774200
- Schroeder TM, Jensen ED and Westendorf JJ (2005) Runx2: a master organizer of gene transcription in developing and maturing osteoblasts. Birth Defects Res C Embryo Today 75, 213-225 https://doi.org/10.1002/bdrc.20043
- Boyce BF, Yao Z and Xing L (2010) Functions of nuclear factor kappaB in bone. Ann N Y Acad Sci 1192, 367-375 https://doi.org/10.1111/j.1749-6632.2009.05315.x
- Kim I, Kim JH, Kim K, Seong S and Kim N (2017) Tusc2/Fus1 regulates osteoclast differentiation through NF-kappaB and NFATc1. BMB Rep 50, 454-459 https://doi.org/10.5483/BMBRep.2017.50.9.026
- Bak SU, Kim S, Hwang HJ et al (2017) Heme oxygenase-1 (HO-1)/carbon monoxide (CO) axis suppresses RANKL-induced osteoclastic differentiation by inhibiting redox-sensitive NF-kappaB activation. BMB Rep 50, 103-108 https://doi.org/10.5483/BMBRep.2017.50.2.220
- Yamashita T, Yao Z, Li F et al (2007) NF-kappaB p50 and p52 regulate receptor activator of NF-kappaB ligand (RANKL) and tumor necrosis factor-induced osteoclast precursor differentiation by activating c-Fos and NFATc1. J Biol Chem 282, 18245-18253 https://doi.org/10.1074/jbc.M610701200
- Yamazaki M, Fukushima H, Shin M et al (2009) Tumor necrosis factor alpha represses bone morphogenetic protein (BMP) signaling by interfering with the DNA binding of Smads through the activation of NF-kappaB. J Biol Chem 284, 35987-35995 https://doi.org/10.1074/jbc.M109.070540
- Yao Z, Li Y, Yin X, Dong Y, Xing L and Boyce BF (2014) NF-kappaB RelB negatively regulates osteoblast differentiation and bone formation. J Bone Miner Res 29, 866-877 https://doi.org/10.1002/jbmr.2108
- Lee J, Youn BU, Kim K et al (2015) Mst2 Controls Bone Homeostasis by Regulating Osteoclast and Osteoblast Differentiation. J Bone Miner Res 30, 1597-1607 https://doi.org/10.1002/jbmr.2503
- Nayak L, Goduni L, Takami Y et al (2013) Kruppel-like factor 2 is a transcriptional regulator of chronic and acute inflammation. Am J Pathol 182, 1696-1704 https://doi.org/10.1016/j.ajpath.2013.01.029
- Dang DT, Pevsner J and Yang VW (2000) The biology of the mammalian Kruppel-like family of transcription factors. Int J Biochem Cell Biol 32, 1103-1121 https://doi.org/10.1016/S1357-2725(00)00059-5
- Das H, Kumar A, Lin Z et al (2006) Kruppel-like factor 2 (KLF2) regulates proinflammatory activation of monocytes. Proc Natl Acad Sci U S A 103, 6653-6658 https://doi.org/10.1073/pnas.0508235103
- Das M, Lu J, Joseph M et al (2012) Kruppel-like factor 2 (KLF2) regulates monocyte differentiation and functions in mBSA and IL-1beta-induced arthritis. Curr Mol Med 12, 113-125 https://doi.org/10.2174/156652412798889090
- Childs KS and Goodbourn S (2003) Identification of novel co-repressor molecules for Interferon Regulatory Factor-2. Nucleic Acids Res 31, 3016-3026 https://doi.org/10.1093/nar/gkg431
- Carneiro FR, Ramalho-Oliveira R, Mognol GP and Viola JP (2011) Interferon regulatory factor 2 binding protein 2 is a new NFAT1 partner and represses its transcriptional activity. Mol Cell Biol 31, 2889-2901 https://doi.org/10.1128/MCB.00974-10
- Teng AC, Kuraitis D, Deeke SA et al (2010) IRF2BP2 is a skeletal and cardiac muscle-enriched ischemia-inducible activator of VEGFA expression. FASEB J 24, 4825-4834 https://doi.org/10.1096/fj.10-167049
- Chen HH, Keyhanian K, Zhou X et al (2015) IRF2BP2 Reduces Macrophage Inflammation and Susceptibility to Atherosclerosis. Circ Res 117, 671-683 https://doi.org/10.1161/CIRCRESAHA.114.305777
- Jha P and Das H (2017) KLF2 in Regulation of NF-kappaB-Mediated Immune Cell Function and Inflammation. Int J Mol Sci 18, 2383-2420 https://doi.org/10.3390/ijms18112383
- SenBanerjee S, Lin Z, Atkins GB et al (2004) KLF2 Is a novel transcriptional regulator of endothelial proinflammatory activation. J Exp Med 199, 1305-1315 https://doi.org/10.1084/jem.20031132
- Boyce BF, Xiu Y, Li J, Xing L and Yao Z (2015) NF-kappaB-Mediated Regulation of Osteoclastogenesis. Endocrinol Metab (Seoul) 30, 35-44 https://doi.org/10.3803/EnM.2015.30.1.35
- Chang J, Wang Z, Tang E et al (2009) Inhibition of osteoblastic bone formation by nuclear factor-kappaB. Nat Med 15, 682-689 https://doi.org/10.1038/nm.1954
- Cao Z, Sun X, Icli B, Wara AK and Feinberg MW (2010) Role of Kruppel-like factors in leukocyte development, function, and disease. Blood 116, 4404-4414 https://doi.org/10.1182/blood-2010-05-285353
- Zhang H and Reilly MP (2015) IRF2BP2: A New Player at the Crossroads of Inflammation and Lipid Metabolism. Circ Res 117, 656-658 https://doi.org/10.1161/CIRCRESAHA.115.307245
- Zhou B, Cron RQ, Wu B et al (2002) Regulation of the murine Nfatc1 gene by NFATc2. J Biol Chem 277, 10704-10711 https://doi.org/10.1074/jbc.M107068200
- Ikeda F, Nishimura R, Matsubara T et al (2004) Critical roles of c-Jun signaling in regulation of NFAT family and RANKL-regulated osteoclast differentiation. J Clin Invest 114, 475-484 https://doi.org/10.1172/JCI200419657